Drug Manufacturer Price Hikes Offset by Rebates
December 20, 2018
(Washington, D.C.) — Pharmaceutical Care Management Association (PCMA) President and CEO JC Scott issued the following statement on reports that...
Filter by:
Highlights
Filter by Year:Clear Filters- Highlights
- Biosimilars
- Drug Abuse Prevention
- Drug Cost Management
- Drug Coupons & Assistance Programs
- Drug Coverage Mandates
- Drug Price Negotiations & Rebates
- Formulary Design
- Fraud
- Fraud, Waste, & Abuse
- Generic Drug Utilization
- Home Delivery of Drugs
- Mark Merritt
- Medicaid
- Medicare Part D
- Patient Cost Sharing
- Pharmacy Networks
- Pharmacy Reimbursement & Contracting
- Specialty Pharmacies
- TRICARE
- Waste
November 14, 2018
The drug giants moved in near-perfect synchronicity, raising prices for their top-selling arthritis treatments as though they were opposite-corner gas...
Morning Consult: Will the Trump Drug-Pricing Initiative Wreck the Medicare Part D Success Story?
November 09, 2018
First, rebates are directly responsible for lowering Part D premiums and program spending....
MarketWatch: Pfizer will go back to price hikes ‘as normal’ come January, CEO suggests
October 31, 2018
Pfizer Inc. will likely go back to “business as normal” for drug price increases...
The Cleveland Plain Dealer: Corral Ohio’s Medicaid ‘Pac-Man’
October 09, 2018
Ohio Medicaid takes better advantage of the expansive industry relationships and pharmacy networks that PBMs have built to provide patients...
Pittsburgh Post-Gazette: We must make prescription drugs affordable
October 09, 2018
PBMs are projected to save $654 billion dollars on drug costs on behalf of 266 million Americans...
Kaiser Health News: Drugmakers Play The Patent Game To Lock In Prices, Block Competitors
October 03, 2018
FDA Commissioner Scott Gottlieb calls “patent thickets,” claiming multiple patents for a single drug to build protection from competitors...
Forbes: Abolishing Drug Rebates May Push Consumer Drug Costs Higher
September 27, 2018
In fact, there is considerable evidence that rebates help reduce drug costs...
The Wall Street Journal: Drug Rebates Aren’t ‘Kickbacks’
September 17, 2018
Consumers also benefit directly from rebates paid to PBMs...
The Weekly Standard: A Great Way to Increase Drug Costs Even More
September 17, 2018
Rebates are the mechanism through which insurers and PBMs achieve discounts from the “list” price for drugs....
STAT News: Rush to end drug rebates may be bad for patients, payers, and pharma
September 07, 2018
Rebates for drugs have worked for decades to provide a mechanism for health plans and their clients to negotiate drug...
The Washington Post: Rebates aren’t the problem. Drug companies’ prices are
September 04, 2018
The president has made it very clear he wants the same thing Americans want: for drug companies to lower their...